Company / R&D per Share
Eton Pharmaceuticals, Inc. R&D per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.13
FY2025
5-year range
$0.13 / $0.57
FY2021-FY2025
Trend
-18.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has declined for 3 consecutive years, from $0.57 in FY2022 to $0.13 in FY2025.
Based on SEC 10-K filings.
0.13 in FY2025 with a 5-year CAGR of -16.3%.
Declined from $0.26 to $0.13 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -39.1%
- 5-Year CAGR
- -16.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- Eton Pharmaceuticals, Inc.'s r&d per share has declined for 3 consecutive years.
- In FY2025, r&d per share decreased 18.0% year-over-year.
- Peak r&d per share was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.13 | -18.0% |
| FY2024 | $0.16 | -38.5% |
| FY2023 | $0.26 | -55.2% |
| FY2022 | $0.57 | +20.5% |
| FY2021 | $0.48 | +51.0% |
| FY2020 | $0.31 | +41.0% |
| FY2019 | $0.22 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026